For example, a defect of function in the TGF-β signalling component leads to carcinogenesis by acting as a definite tumour suppressor during the early phase, but it may exhibit an oncogenic function during later clinical stages (Jakowlew, 2006). The gene discussed is TGFB1; the disease is neoplasm.